pre-seed
Stage
1
Investors
About
Metri Bio develops first-in-class therapeutics targeting endometrial diseases such as endometriosis by creating improved disease models and disease-modifying treatments.
Explore Metri Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.